查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2018473

靜脈輸液管路及配件市場：2026-2032年全球市場預測（依產品類型、材料類型、最終用戶、通路及應用分類）

IV Tubing Sets & Accessories Market by Product Type, Material Type, End User, Channel Of Distribution, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，靜脈輸液管及配件市場價值將達到 16.3 億美元，到 2026 年將成長至 17.1 億美元，到 2032 年將達到 24.3 億美元，複合年成長率為 5.86%。

主要市場統計數據
基準年 2025 16.3億美元
預計年份：2026年 17.1億美元
預測年份 2032 24.3億美元
複合年成長率 (%) 5.86%

全面介紹臨床需求、材料創新和製造品質如何交織，從而塑造靜脈輸液管路套裝和配件的發展。

靜脈輸液管路及其配件在現代醫療保健中發揮著至關重要的作用，它們是向體內輸送維持生命的液體、藥物、血液製品和營養物質的物理通道。這些產品兼具相對簡單的機械設計和嚴格的臨床性能要求，其研發體現了材料科學、使用者工程、感染控制和生產品管系統之間的持續互動。隨著醫療專業人員不斷追求安全性和操作效率的提升，人們對輸液管路及其配件的期望也在不斷提高，要求其具備更強的生物相容性、抗扭轉性、精確的流量控制以及與先進輸液泵和封閉式輸液裝置的兼容性。

對臨床、監管和技術領域中重新定義整個輸液設備生態系統供應鏈和產品優先事項的協同因素進行詳細分析。

靜脈輸液管路及配件的市場格局正經歷變革，這主要歸因於臨床實務、監管框架和技術進步等多種因素的相互作用。在臨床方面，門診和居家輸液的普及重新定義了設備易用性的要求，促使人們更加關注簡化的連接器和可由非醫療專業人員安全操作的輸液系統。同時，人們對導管相關感染疾病和給藥錯誤的日益重視，加速了封閉式系統、無針連接器和最小化操作設計的應用。這些臨床壓力迫使供應商優先考慮易用性、清晰的標籤以及支援不同醫療機構標準化的設計。

對 2025 年關稅調整將如何影響靜脈輸液管製造商和買家的採購、材料選擇和供應鏈韌性的策略性展望。

美國計劃於2025年調整關稅政策，將對包括靜脈輸液管路及配件在內的醫療耗材的成本和供應動態產生重大影響。進口原料和成品組件的關稅可能會改變接收成本，促使製造商和醫療採購商重新評估籌資策略。為此，許多製造商可能會加快供應商多元化，探索替代聚合物來源，或增加對國內契約製造製造商的依賴。這些調整可能涉及認證、監管檢驗和物流重組等過渡成本，也可能促使企業進行長期投資，建立本地生產能力，以降低關稅變化的影響。

詳細的細分分析揭示了產品類型、材料、最終用戶、通路和臨床應用如何全面影響採購行為和創新重點。

細分市場分析揭示了因產品類型、材料成分、終端用戶環境、分銷管道和臨床應用而異的細微需求模式，這些因素共同影響相關人員的優先事項和競爭動態。根據產品類型，產業關注分散在以下幾個方面：用於提高手術柔軟性的延長管、針對低流量和兒童給藥最佳化的微孔導管、可實現同步治療的多腔導管以及用於常規輸注的標準導管。材料選擇在性能和可接受性方面起著至關重要的作用，聚乙烯和聚氨酯具有不同的柔軟性和拉伸性能，聚氯乙烯 (PVC) 提供經濟高效的透明度和易加工性，而矽膠則滿足對柔軟性和生物相容性要求極高的特殊需求。產品設計與材料選擇之間的相互作用通常不僅決定了臨床適用性，也決定了製造的複雜性。

從關鍵區域觀點闡述美洲、歐洲、中東和非洲以及亞太地區如何塑造其採購重點、監管重點和供應商策略。

區域趨勢對靜脈輸液管路及配件的需求促進因素、法規要求和供應鏈結構有顯著影響。在美洲，大規模醫院系統間的整合正在不斷推進，而居家醫療領域仍然保持強勁勢頭，從而催生了對標準化散裝產品和便捷的家用輸液解決方案的需求。該地區的法規環境著重於供應商合格和上市後監管，而報銷機制和分銷網路則影響採購時間和合約條款。相較之下，歐洲、中東和非洲（EMEA）地區的管理體制、多元化的公共採購模式以及不同的臨床引進週期之間存在著複雜的相互作用。在該地區，一些市場優先考慮永續性和減少一次性產品的舉措，而另一些市場則強調成本控制和在地化生產的激勵措施。

該行業普遍採用具有高影響力的企業策略，重點是突出市場領先的創新、卓越的製造流程、夥伴關係以及不斷發展的分銷管道。

靜脈輸液管及配件領域的主要企業正致力於產品差異化、卓越營運和策略夥伴關係，以保持其競爭力。創新重點在於材料科學的改進，從而提升生物相容性和抗彎強度；開發可降低感染風險的連接系統；以及採用模組化設計，簡化臨床醫生的工作流程。同時，各企業正透過檢驗的品質體系、供應商可追溯性和嚴格的變更控制流程，優先保障生產的穩健性，以滿足監管要求，並縮短迭代改進產品的上市時間。

針對製造商和醫療保健採購者的具體建議，以加強材料策略、實現製造流程多樣化，並使產品價值與臨床安全要求保持一致。

產業領導企業應採取積極主動的方式，使產品創新、供應鏈韌性和商業性可行性與不斷變化的臨床和監管要求保持一致。首先，優先考慮材料策略能帶來顯著成效。將聚乙烯、聚氨酯、聚氯乙烯和矽膠替代品的嚴格合格流程與加速生物相容性測試相結合，可在需要替代方案時減少時間和風險。其次，實現製造地多元化，並在多個地區建立檢驗的契約製造關係，可以縮短醫院和診所的前置作業時間，同時降低關稅和物流中斷風險。第三，投資於連接器標準化和封閉式系統可以解決臨床醫生的安全顧慮，並且在以感染預防為關鍵標準的競標過程中，可以成為一項差異化優勢。

透明的調查方法結合了臨床和相關人員的初步訪談、技術文獻綜述和供應鏈分析，確保了可靠、可操作的見解。

本研究採用混合方法，結合與關鍵相關人員的對話、技術文獻回顧和供應鏈分析，對靜脈輸液管路及配件的現狀進行了全面分析。主要調查包括對臨床醫生、採購經理、法規專家和生產主管進行結構化訪談，以收集有關臨床需求、採購決定因素和營運限制的第一手資訊。此外，還分析了法規指導文件、生物相容性和滅菌標準以及生產最佳實踐，從而在現有合規框架內為研究結果提供了支持。

總結總結強調了臨床需求、材料創新和供應鏈韌性之間的相互作用，認為這是決定輸液設備市場競爭成功的關鍵因素。

總之，靜脈輸液管路及配件在醫療保健領域仍然是一個至關重要且充滿活力的類別，其發展受到臨床需求訊號、材料創新、監管進步以及不斷演變的供應鏈結構的影響。該領域的特點是產品不斷創新，以滿足臨床醫生對安全性的關注以及醫院外持續護理的需求。同時，關稅政策調整和區域製造能力擴張等宏觀層面的影響正迫使相關人員重新評估其籌資策略，實現供應商關係多元化，並加快替代材料的認證流程。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：靜脈輸液管路及配件市場：依產品類型分類

  • 延長管
  • 微型鑽孔
  • 多流明
  • 標準

第9章：靜脈輸液管路及配件市場：依材料類型分類

  • 聚乙烯
  • 聚氨酯
  • PVC
  • 矽酮

第10章 靜脈輸液管路及配件市場：依最終用戶分類

  • 門診治療
  • 診所
    • 整體的
    • 專業
  • 居家醫療
  • 醫院
    • 私人的
    • 民眾

第11章 依銷售管道分類的靜脈輸液管及配件市場

  • 醫院藥房
  • 線上
    • 製造商官方網站
    • 第三方電子商務網站
  • 零售藥房
    • 鏈
    • 獨立的
  • 批發的
    • 綜合型
    • 專業

第12章 靜脈輸液管路及配件市場：依應用領域分類

  • 輸血
    • 電漿
    • 血小板
    • 紅血球
  • 藥物管理
    • Bolus
    • 受控管理
  • 靜脈注射
    • 維持
    • 間歇性的
  • 腸外營養

第13章 靜脈輸液管路及配件市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 靜脈輸液管及配件市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 靜脈輸液管路及配件市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國靜脈輸液管及配件市場

第17章：中國輸液管路及配件市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AdvaCare
  • Amsino International Inc
  • AngioDynamics Inc
  • B. Braun Melsungen AG
  • Baxter International Inc
  • Becton Dickinson and Company
  • CR Bard Inc
  • Cardinal Health Inc
  • Codan Medizinische Gerate
  • Dynarex Corporation
  • Fresenius Kabi AG
  • Health Line International Corporation
  • Hospira Inc
  • ICU Medical Inc
  • Medline Industries LP
  • Medtronic plc
  • Moog Inc
  • Nipro Corporation
  • Perfect Medical Ind Co Ltd
  • Polymedicure Ltd
  • Romsons International
  • Smiths Medical
  • Terumo Corporation
  • Vygon SA
  • Zyno Medical LLC
Product Code: MRR-A339DAEF9E5F

The IV Tubing Sets & Accessories Market was valued at USD 1.63 billion in 2025 and is projected to grow to USD 1.71 billion in 2026, with a CAGR of 5.86%, reaching USD 2.43 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.63 billion
Estimated Year [2026] USD 1.71 billion
Forecast Year [2032] USD 2.43 billion
CAGR (%) 5.86%

Comprehensive introduction outlining how clinical demands, material innovation, and manufacturing quality converge to shape intravenous tubing sets and accessory development

Intravenous tubing sets and accessories occupy a foundational role in contemporary healthcare delivery, serving as the physical conduit for life-sustaining fluids, drugs, blood products, and nutrition. These products combine relatively simple mechanical design with stringent clinical performance expectations, and their development reflects a continuous interplay between material science, user ergonomics, infection prevention, and manufacturing quality systems. As healthcare providers pursue higher standards of safety and operational efficiency, the expectations placed on tubing sets and ancillary devices have evolved to include improved biocompatibility, kink resistance, precise flow control, and compatibility with advanced infusion pumps and closed-system transfer devices.

Across care settings, from acute hospital wards to ambulatory clinics and home healthcare environments, clinicians and procurement teams increasingly prioritize devices that reduce infection risk, minimize medication errors, and simplify care pathways. Consequently, manufacturers are investing in incremental innovation across product families, including microbore lines engineered for pediatric and low-flow applications, multi-lumen configurations that facilitate simultaneous therapies, and extension sets designed for procedural flexibility. At the same time, material selection and supply chain continuity are central determinants of product performance and cost competitiveness. Therefore, an integrated view of clinical needs, regulatory requirements, and supplier capabilities is essential for stakeholders seeking to align product portfolios with evolving standards of care and operational imperatives.

Detailed analysis of converging clinical, regulatory, and technological forces that are redefining supply chains and product priorities across infusion device ecosystems

The landscape for intravenous tubing sets and accessories is undergoing transformative shifts driven by converging forces across clinical practice, regulation, and technology. Clinically, the drive toward outpatient care and home-based infusions is reshaping device usability requirements, increasing demand for simplified connectors and infusion systems that non-clinical caregivers can manage safely. Simultaneously, heightened awareness of catheter-associated infections and medication administration errors has accelerated adoption of closed systems, needleless connectors, and designs that limit manipulation. These clinical pressures are pushing suppliers to prioritize ease of use, clear labeling, and designs that support standardization across care sites.

On the regulatory front, jurisdictions are tightening scrutiny on biocompatibility and material traceability, which compels manufacturers to enhance documentation, validation, and supplier audits. Technological advances are also reshaping product capabilities: additive manufacturing and precision extrusion techniques are improving tolerances for microbore and multi-lumen tubing, while analytics and digital tools enable better quality monitoring across production and distribution. In parallel, procurement teams are responding to cost pressures by diversifying sourcing strategies, including nearshoring and multi-sourcing, which alters supplier relationships and contract dynamics. Taken together, these shifts are producing a more complex, but also more opportunity-rich, marketplace for organizations that can combine regulatory excellence, materials expertise, and user-centered design to meet the changing needs of clinicians and patients.

Strategic perspective on how 2025 tariff adjustments will reshape sourcing, material selection, and supply chain resilience for infusion tubing manufacturers and purchasers

United States tariff policy changes slated for 2025 introduce a material variable into the cost and supply dynamics of medical consumables, including intravenous tubing sets and accessories. Tariffs on imported raw materials or finished components can alter landed costs, prompting manufacturers and healthcare purchasers to reassess sourcing strategies. In response, many manufacturers may accelerate supplier diversification, seek alternative polymer sources, or increase reliance on domestic contract manufacturers. These adjustments are likely to involve transitional costs related to qualification, regulatory revalidation, and logistical reconfiguration, and they may also incentivize longer-term investments in local capacity building to reduce exposure to tariff volatility.

Moreover, tariffs can influence product design decisions. Procurement-driven cost containment may steer material substitution efforts toward polymers that balance cost and clinical performance, while preservational commitments to quality will require robust testing to ensure substitutions do not compromise safety. Transitioning supply chains also affects inventory strategies: healthcare organizations and distributors may choose to hold higher buffer stocks or negotiate longer-term supply agreements to mitigate disruption risk. In addition, manufacturers with vertically integrated operations or strategic partnerships in low-tariff jurisdictions may gain relative advantage, forcing competitors to pursue consolidation or differentiated value propositions centered on service, quality, and regulatory reliability. Ultimately, the cumulative impact of tariff changes will be mediated by how swiftly stakeholders adapt procurement policies, validate alternative materials, and realign manufacturing footprints.

In-depth segmentation insights revealing how product types, materials, end users, distribution routes, and clinical applications collectively drive procurement behavior and innovation priorities

Segmentation analysis reveals nuanced demand patterns that vary according to product type, material composition, end-user environment, channels of distribution, and clinical application, each shaping stakeholder priorities and competitive dynamics. Based on product type, industry attention is distributed across extension sets for procedural flexibility, microbore tubing optimized for low-flow and pediatric administration, multi-lumen formats that enable concurrent therapies, and standard tubing employed in routine infusions. Material selection plays a central role in performance and acceptance, with polyethylene and polyurethane offering distinct flexibility and tensile properties, PVC providing cost-efficient clarity and processing familiarity, and silicone serving specialty needs where softness and biocompatibility are paramount. The interplay between product design and material choice often dictates clinical suitability as well as manufacturing complexity.

End users exhibit differentiated preferences that influence procurement and product development, with ambulatory care sites, clinics, home healthcare settings, and hospitals each demanding tailored solutions. Within clinics, general practice settings prioritize ease of use and cost-effectiveness while specialty clinics require compatibility with nuanced therapeutic protocols. Hospitals present a bifurcation between private and public institutions, each with distinct procurement mechanisms and standardization pressures. Channel dynamics further modulate market access and purchasing behavior: hospital pharmacies continue to be a primary procurement node, while online channels-both direct manufacturer websites and third-party e-commerce platforms-are expanding convenience and reach. Retail pharmacy distribution spans chain and independent outlets, and wholesalers operate through full-service and specialized models to meet different inventory and logistics needs. Finally, applications such as blood transfusion, drug administration, infusion, and parenteral nutrition impose rigorous performance and regulatory requirements, with subcategories like plasma, platelets, red blood cells, bolus versus controlled administration, and continuous versus intermittent infusion driving specific product attributes and clinical training considerations. Understanding how these segmentation dimensions interconnect allows product managers and procurement leaders to tailor offerings, prioritize development investments, and design distribution strategies that align with clinical workflows and regulatory demands.

Key regional perspectives describing how the Americas, Europe Middle East & Africa, and Asia-Pacific each shape procurement priorities, regulatory focus, and supplier strategies

Regional dynamics exert a profound influence on demand drivers, regulatory requirements, and supply chain architecture for intravenous tubing sets and accessories. In the Americas, a high degree of consolidation among large hospital systems coexists with a robust home healthcare segment, creating demand for both standardized bulk products and consumer-friendly home infusion solutions. This region's regulatory environment emphasizes supplier qualification and post-market surveillance, while reimbursement structures and distribution networks shape procurement windows and contract terms. In contrast, Europe, Middle East & Africa presents a complex mosaic of regulatory regimes, varying public procurement models, and divergent clinical adoption cycles; certain markets within the region prioritize sustainability and single-use reduction initiatives, whereas others emphasize cost containment and local manufacturing incentives.

Asia-Pacific displays rapid growth in demand across hospital expansions and outpatient facilities, accompanied by a mix of established multinational suppliers and emergent local manufacturers. Regulatory harmonization efforts and rising local manufacturing capability are encouraging greater domestic production, which in turn affects global supply chains and pricing dynamics. Across all regions, differences in clinician training, infection control protocols, and infrastructure maturity shape product requirements-from advanced multi-lumen lines in tertiary centers to robust, easy-to-use sets for community and home care. Consequently, regional strategies must balance global quality standards with localized product configurations, channel approaches, and supplier relationships to meet heterogeneous clinical and procurement needs effectively.

High-impact corporate strategies observed across the sector highlighting innovation, manufacturing excellence, partnerships, and distribution channel evolution that define market leadership

Leading companies in the intravenous tubing and accessories sector are pursuing a mix of product differentiation, operational excellence, and strategic partnerships to sustain competitiveness. Innovation is concentrated on material science improvements that deliver better biocompatibility and kink resistance, the development of connector systems that reduce infection risk, and modular designs that ease clinician workflows. Concurrently, firms emphasize manufacturing robustness through validated quality systems, supplier traceability, and rigorous change control processes to meet regulatory expectations and reduce time-to-market for iterative improvements.

Strategic collaborations with contract manufacturers, medical device startups, and clinical research centers are common, enabling larger firms to accelerate capability expansion without bearing the full cost of in-house R&D. Distribution strategies are also evolving: some companies are strengthening direct-to-provider channels and digital commerce capabilities, while others leverage wholesaler networks and hospital pharmacy partnerships to maintain coverage across diverse end-user segments. Financially, corporate actions such as targeted acquisitions of niche technology providers, investments in localized manufacturing capacity, and long-term supply agreements with polymer producers are being used to secure raw material access and mitigate tariff or logistics risk. Ultimately, companies that combine clinical insight, disciplined quality management, and agile distribution models are better positioned to meet complex customer requirements and respond to regulatory change.

Actionable recommendations for manufacturers and healthcare purchasers to strengthen materials strategy, diversify manufacturing, and align product value with clinical safety imperatives

Industry leaders should adopt a proactive agenda that aligns product innovation, supply chain resilience, and commercial execution with evolving clinical and regulatory requirements. First, prioritizing materials strategy will pay dividends: rigorous qualification pathways for polyethylene, polyurethane, PVC, and silicone alternatives, coupled with accelerated biocompatibility testing, can reduce time and risk when substitutions are required. Second, diversifying manufacturing footprints and establishing validated contract manufacturing relationships in multiple geographies will mitigate tariff and logistical disruption risks while enabling more responsive lead times for hospitals and clinics. Third, investing in connector standardization and closed systems will address clinician safety concerns and can be a differentiator in tender processes where infection prevention is a central criterion.

Additionally, companies should enhance digital engagement and channel flexibility by building direct-to-provider commerce capabilities and strengthening third-party e-commerce partnerships, while ensuring that hospital pharmacy, retail, and wholesale relationships remain optimized through service-level agreements and inventory management solutions. From an organizational perspective, embedding regulatory intelligence into product development cycles and maintaining proactive post-market surveillance will smooth approval pathways and support claims substantiation. Finally, leading with value-based propositions-linking device attributes to reduced adverse events, simplified workflows, or total cost of care-will resonate with procurement teams seeking sustainable clinical and economic outcomes. Taken together, these actions will position organizations to capture opportunities created by shifting care settings, regulatory tightening, and supply chain realignment.

Transparent research methodology combining primary clinical and procurement interviews with technical literature review and supply chain mapping to ensure robust, actionable findings

This research synthesis is built on a mixed-methods approach that integrates primary stakeholder engagement, technical literature review, and supply chain mapping to produce a comprehensive view of the intravenous tubing sets and accessories landscape. Primary research involved structured interviews with clinicians, procurement leaders, regulatory specialists, and manufacturing executives to capture firsthand insights into clinical needs, purchasing drivers, and operational constraints. These qualitative inputs were complemented by an analysis of regulatory guidance documents, standards for biocompatibility and sterilization, and manufacturing best practices to ground findings in current compliance frameworks.

Supply chain analysis mapped upstream polymer sourcing, extruder capabilities, and downstream distribution channels to identify potential bottlenecks and resilience strategies. Data validation included cross-referencing interview-derived themes with proprietary quality assurance documentation and manufacturing process benchmarks. Where possible, triangulation techniques were used to reconcile divergent perspectives and ensure robustness of conclusions. Limitations of the methodology include variability in regional regulatory interpretations and the proprietary nature of some contract manufacturing agreements, which can constrain visibility into certain cost structures. Nevertheless, the combined methodological approach provides a reliable basis for strategic decision-making by linking clinical imperatives, material science considerations, and operational realities.

Conclusive synthesis emphasizing the interplay of clinical needs, material innovation, and supply chain resilience as determinants of competitive success in infusion device markets

In conclusion, intravenous tubing sets and accessories remain a critical yet dynamic category within healthcare delivery, shaped by clinical demand signals, material innovation, regulatory evolution, and shifting supply chain architectures. The sector is characterized by incremental product innovation that responds to clinician safety concerns and the expanding continuum of care beyond hospital walls. At the same time, macro-level influences such as tariff policy adjustments and regional manufacturing capacity development are prompting stakeholders to rethink sourcing strategies, diversify supplier relationships, and accelerate qualification of alternative materials.

Moving forward, organizations that integrate clinical insights into product development, secure resilient and flexible manufacturing arrangements, and articulate clear value propositions tied to safety and workflow efficiency will be best positioned to navigate uncertainty and capture the benefits of shifting care paradigms. Collaboration across the value chain-including manufacturers, distributors, clinicians, and regulatory bodies-will be essential to ensure that product innovation translates into measurable clinical improvements and operational advantages. Ultimately, a disciplined focus on quality, regulatory readiness, and customer-centric design will determine which players succeed in this evolving environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. IV Tubing Sets & Accessories Market, by Product Type

  • 8.1. Extension
  • 8.2. Microbore
  • 8.3. Multi-Lumen
  • 8.4. Standard

9. IV Tubing Sets & Accessories Market, by Material Type

  • 9.1. Polyethylene
  • 9.2. Polyurethane
  • 9.3. PVC
  • 9.4. Silicone

10. IV Tubing Sets & Accessories Market, by End User

  • 10.1. Ambulatory Care
  • 10.2. Clinics
    • 10.2.1. General
    • 10.2.2. Specialty
  • 10.3. Home Healthcare
  • 10.4. Hospitals
    • 10.4.1. Private
    • 10.4.2. Public

11. IV Tubing Sets & Accessories Market, by Channel Of Distribution

  • 11.1. Hospital Pharmacy
  • 11.2. Online
    • 11.2.1. Direct Manufacturer Website
    • 11.2.2. Third-Party E-Commerce
  • 11.3. Retail Pharmacy
    • 11.3.1. Chain
    • 11.3.2. Independent
  • 11.4. Wholesale
    • 11.4.1. Full-Service
    • 11.4.2. Specialized

12. IV Tubing Sets & Accessories Market, by Application

  • 12.1. Blood Transfusion
    • 12.1.1. Plasma
    • 12.1.2. Platelets
    • 12.1.3. Red Blood Cells
  • 12.2. Drug Administration
    • 12.2.1. Bolus
    • 12.2.2. Controlled
  • 12.3. Infusion
    • 12.3.1. Continuous
    • 12.3.2. Intermittent
  • 12.4. Parenteral Nutrition

13. IV Tubing Sets & Accessories Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. IV Tubing Sets & Accessories Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. IV Tubing Sets & Accessories Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States IV Tubing Sets & Accessories Market

17. China IV Tubing Sets & Accessories Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AdvaCare
  • 18.6. Amsino International Inc
  • 18.7. AngioDynamics Inc
  • 18.8. B. Braun Melsungen AG
  • 18.9. Baxter International Inc
  • 18.10. Becton Dickinson and Company
  • 18.11. C.R. Bard Inc
  • 18.12. Cardinal Health Inc
  • 18.13. Codan Medizinische Gerate
  • 18.14. Dynarex Corporation
  • 18.15. Fresenius Kabi AG
  • 18.16. Health Line International Corporation
  • 18.17. Hospira Inc
  • 18.18. ICU Medical Inc
  • 18.19. Medline Industries LP
  • 18.20. Medtronic plc
  • 18.21. Moog Inc
  • 18.22. Nipro Corporation
  • 18.23. Perfect Medical Ind Co Ltd
  • 18.24. Polymedicure Ltd
  • 18.25. Romsons International
  • 18.26. Smiths Medical
  • 18.27. Terumo Corporation
  • 18.28. Vygon SA
  • 18.29. Zyno Medical LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL IV TUBING SETS & ACCESSORIES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES IV TUBING SETS & ACCESSORIES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA IV TUBING SETS & ACCESSORIES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY EXTENSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY EXTENSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY EXTENSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MICROBORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MICROBORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MICROBORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MULTI-LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MULTI-LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MULTI-LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY STANDARD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY STANDARD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY GENERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY GENERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY GENERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SPECIALTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SPECIALTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SPECIALTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DIRECT MANUFACTURER WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DIRECT MANUFACTURER WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DIRECT MANUFACTURER WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY THIRD-PARTY E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY THIRD-PARTY E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY THIRD-PARTY E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INDEPENDENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY FULL-SERVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY FULL-SERVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY FULL-SERVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SPECIALIZED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SPECIALIZED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SPECIALIZED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PLATELETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PLATELETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PLATELETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RED BLOOD CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RED BLOOD CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BOLUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BOLUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BOLUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CONTROLLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CONTROLLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CONTROLLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CONTINUOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INTERMITTENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INTERMITTENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INTERMITTENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, 2018-2032 (USD MILLION)
  • TABLE 254. GCC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 255. GCC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. GCC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. GCC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. GCC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 259. GCC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 260. GCC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 261. GCC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 262. GCC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 263. GCC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, 2018-2032 (USD MILLION)
  • TABLE 264. GCC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. GCC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 266. GCC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 267. GCC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, 2018-2032 (USD MILLION)
  • TABLE 296. G7 IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 297. G7 IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. G7 IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. G7 IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. G7 IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 301. G7 IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 302. G7 IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 303. G7 IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 304. G7 IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 305. G7 IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, 2018-2032 (USD MILLION)
  • TABLE 306. G7 IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. G7 IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 308. G7 IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 309. G7 IV TUBING SETS & ACC